Skip to content
Menu

Astellas Pharma Inc. ALPMY

Full chart Compare
Set alert

Price alert · ALPMY

All alert types
16.85 USD +0.34 (+2.06%)

Regular-session close

16.75 Day range 17.38
11.97 52-week range 16.85
YTD
+26.79%
1 year
+40.77%

Revenue & Expenses

Revenue → Gross Profit: $1.69TGross Profit → Net Income: $309.12BGross Profit → Selling, General & Admin: $912.20BGross Profit → Research & Development: $333.81BRevenue → Cost of Revenue: $577.24BGross Profit → Interest Expense: $14.92BGross Profit → Other Expenses: $30.83BGross Profit → Income Tax: $90.14BGross Profit$1.69TCost of Revenue$577.24BNet Income$309.12BSelling, General & Admin$912.20BResearch & Development$333.81BInterest Expense$14.92BOther Expenses$30.83BIncome Tax$90.14BRevenue$2.27T

No annual statement lines

ALPMY has no annual lines for this statement.